Bafna Pharmaceuticals Performance
- Today's Low
- ₹161
- Today's High
- ₹168
- 52 Week Low
- ₹73
- 52 Week High
- ₹213
- Open Price₹163
- Previous Close₹160
- Volume13,861
- 50 DMA₹144.29
- 100 DMA₹137.10
- 200 DMA₹129.23
Bafna Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 23.81%
- Over 3 Month + 33.55%
- Over 6 Month + 12.37%
- Over 1 Year + 125.76%
Smart Investing Starts Here Start SIP with Bafna Pharmaceuticals for Steady Growth!
Bafna Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 35.8
- PEG Ratio
- 0.2
- Market Cap Cr
- 398
- P/B Ratio
- 4.1
- Average True Range
- 10.67
- EPS
- 4.69
- Dividend Yield
- 0
- MACD Signal
- 7.59
- RSI
- 54.73
- MFI
- 46.66
Latest Stock News Updates
NULL
- Moneycontrol
- 4 years 4 months ago
Pharmaceuticals formulations major Bafna Pharmaceuticals Ltd was in advanced stage of discussion with some multi-national pharma companies for acquisitions of brands, a company official said.
- Business Standard
- 4 years 7 months ago
NULL
- Moneycontrol
- 4 years 10 months ago
Bafna Pharmaceuticals Financials
Bafna Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹155.20
- 50 Day
- ₹144.30
- 100 Day
- ₹137.10
- 200 Day
- ₹129.20
Resistance and Support
- R3 171.59
- R2 166.83
- R1 163.51
- S1 155.43
- S2 150.67
- S3 147.35
Bafna Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-29 | Audited Results | |
| 2026-02-11 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results |
About Bafna Pharmaceuticals
- NSE Symbol
- BAFNAPH
- BSE Symbol
- 532989
- ISIN
- INE878I01022
Similar Stocks to Bafna Pharmaceuticals
Popular Stocks
Bafna Pharmaceuticals FAQs
Bafna Pharmaceuticals share price is ₹168 As on 22 June, 2026 | 10:17
The Market Cap of Bafna Pharmaceuticals is ₹397.9 Cr As on 22 June, 2026 | 10:17
The P/E ratio of Bafna Pharmaceuticals is 35.8 As on 22 June, 2026 | 10:17
The PB ratio of Bafna Pharmaceuticals is 4.1 As on 22 June, 2026 | 10:17
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.